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Abstract
Arboviral diseases have risen significantly over the last 40 years,
increasing the risk of co-infection with other endemic disease such
as malaria. However, nothing is known about the impact arbo-
viruses have on the host response toward heterologous pathogens
during co-infection. Here, we investigate the effects of Chikun-
gunya virus (CHIKV) co-infection on the susceptibility and severity
of malaria infection. Using the Plasmodium berghei ANKA (PbA)
experimental cerebral malaria (ECM) model, we show that concur-
rent co-infection induced the most prominent changes in ECM
manifestation. Concurrent co-infection protected mice from ECM
mortality without affecting parasite development in the blood.
This protection was mediated by the alteration of parasite-specific
CD8+ T-cell trafficking through an IFNc-mediated mechanism. Co-
infection with CHIKV induced higher splenic IFNc levels that lead
to high local levels of CXCL9 and CXCL10. This induced retention of
CXCR3-expressing pathogenic CD8+ T cells in the spleen and
prevented their migration to the brain. This then averts all down-
stream pathogenic events such as parasite sequestration in the
brain and disruption of blood–brain barrier that prevents ECM-
induced mortality in co-infected mice.
Keywords CD8+ T-cell trafficking; Chikungunya; co-infection; malaria
Subject Categories Immunology; Microbiology, Virology & Host Pathogen
Interaction
DOI 10.15252/emmm.201707885 | Received 10 April 2017 | Revised 5 October
2017 | Accepted 10 October 2017 | Published online 7 November 2017
EMBO Mol Med (2018) 10: 121–138
Introduction
With the advent of new and efficient methods to identify and diag-
nose known and emerging pathogens, it is evident that co-infections
are a common phenomenon. Particularly, co-infection with more
than one pathogen such as HIV, Mycobacterium tuberculosis, hepati-
tis viruses, helminths, and Plasmodium has been estimated to affect
about one-third of the human population in developing countries
(Stelekati & Wherry, 2012). Existing epidemiological data suggest a
greater incidence of negative effects on pathogen-specific host
immune responses during co-infection (Stelekati et al, 2014).
However, the underlying mechanisms remain poorly understood
(Stelekati & Wherry, 2012).
Among the prevalent infectious diseases in the world, mosquito-
borne parasites and viruses are frequently co-endemic in inter-
tropical regions. Malaria transmission still persists in 95 countries,
accounting for over 214 million new cases worldwide in 2015
alone (World Health Organization (WHO), 2015). Arthropod-borne
viruses (arboviruses) such as Chikungunya virus (CHIKV), Zika
virus (ZIKV), and dengue virus are also endemic and co-endemic
with malaria in many tropical countries such as Africa, Latin Amer-
ica, and Asia (Power, 2015; WHO, 2015). This occurrence increases
the risks of co-infection in these populations. Classical clinical
symptoms of arboviruses include febrile illness, rashes, and joint
pain. Thus, generic febrile symptoms in arbovirus-infected patients
make clinical identification of their co-infection with malaria
parasites difficult.
Among the arboviruses, co-infection of Plasmodium with CHIKV
has been reported in patients (Hertz et al, 2012; Baba et al, 2013;
Chipwaza et al, 2014; Ayorinde et al, 2016; Waggoner et al, 2017).
In one study, patients were reported to concomitantly harbor
P. falciparum parasites (diagnosed by microscopy) and CHIKV (di-
agnosed by PCR; Hertz et al, 2012). In two other studies, patients
acutely infected with malaria were positive for CHIKV-specific IgM
(Ayorinde et al, 2016) or possessed neutralizing CHIKV-specific
antibodies in their sera (Baba et al, 2013). While these studies
demonstrate that infection by Plasmodium parasites and CHIKV
could occur together, the impact of co-infection on host suscepti-
bility and the respective infection-induced pathologies remain
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unknown. Both diseases induce strong but different dynamics in
innate and adaptive immune responses (Boubou et al, 1999; Renia
et al, 2006; Chirathaworn et al, 2010; Gardner et al, 2010; Hoarau
et al, 2010; Chaaitanya et al, 2011; Claser et al, 2011; Kelvin et al,
2011; Wauquier et al, 2011; Hansen, 2012; Re´nia et al, 2012;
Rovira-Vallbona et al, 2012; Boef et al, 2013; Teo et al, 2013). Thus,
co-infection may modify both kinetics and characteristics of
pathogen-specific immunity that could alter disease outcome, that
is, protection versus immunopathology.
In this study, we explore the effects of CHIKV co-infection on the
susceptibility and severity of malaria infection using a mouse model
of experimental cerebral malaria (ECM) induced by P. berghei
ANKA (PbA).
Results
Concurrent co-infection with CHIKV infection protects mice
from ECM
Different scenarios of co-infection between CHIKV and PbA were
investigated (Fig 1). In the well-established PbA-ECM model, PbA
infection typically results in 70–80% ECM-induced death in mice
between 6 and 12 days post-infection (dpi; Engwerda et al, 2005).
Interestingly, concurrent co-infection with CHIKV protected mice
from death despite similar parasitemia levels during the ECM
window period of 6–12 dpi (Fig 1A). Instead, mice died of hyper-
parasitemia much later at 28 dpi (Fig 1A). Contrastingly, there
was no change in the occurrence of ECM in mice infected with
PbA either 4 days before (Fig 1B), 4 days after (Fig 1C), or
15 days after CHIKV infection (Fig 1D). There was also no change
in parasitemia levels in all sequential infection scenarios (Fig 1B
and D), except for higher parasitemia just prior to and during the
ECM window when CHIKV was inoculated 4 days before PbA
infection (Fig 1C).
Co-infection reduces parasite sequestration in the brain and
preserves the blood–brain barrier (BBB)
One vital characteristic of ECM is sequestration of parasites in the
brain during neurological manifestation (Amante et al, 2010; Claser
et al, 2011; Howland et al, 2013). The PbA clone used in this study
has been genetically modified to express luciferase (Amante et al,
2007) that allows for assessment of parasite sequestration kinetics
in the deep tissues using bioluminescent imaging. Compared to PbA
infection alone, mice concurrently infected with both pathogens had
significantly reduced bioluminescence signals in the whole body
and in the head at 5 dpi (Fig 2A and B). This time point also coin-
cided with the time when singly PbA-infected mice would normally
present mild neurological manifestations. At later time points, dif-
ferences in parasite sequestration were not observed (Fig 2A and
B). To specifically quantify the parasites that sequestered accurately
in the brain, mice were perfused at 6 dpi and the ex vivo biolumi-
nescence signals were recorded from the brains. Expectedly, concur-
rent co-infection reduced the parasite load in the isolated brains at
6 dpi (Fig 2C).
Experimental cerebral malaria mortality is due to a breach of the
blood–brain barrier (BBB) (Thumwood et al, 1988; van der Heyde
et al, 2001). Blood–brain barrier permeability can be quantified by
intravenous injection of Evans blue dye, as this dye is normally
excluded from the brain parenchyma unless the BBB is ruptured
(Clasen et al, 1970). Evans blue permeability assay was performed
when PbA-infected mice began to display neurological symptoms at
6 dpi. Dye levels were significantly higher in all brains compared to
the brains of co-infected mice. As shown by the reduction of dye
recovered from the perfused brain, concurrent co-infection
preserved BBB integrity (Fig 2D). Taken together, protection from
ECM lethality by concurrent CHIKV co-infection is associated with a
reduction in parasite sequestration in the brain and preservation of
BBB integrity.
Co-infection prevents brain endothelium cross-presentation of
parasite-derived antigens
When ECM-susceptible mice develop neurological signs, leukocytes
and in particular parasite-specific CD8+ T cells accumulate in the
brain (Belnoue et al, 2002; Howland et al, 2013). These CD8+ T
cells have been shown to recognize parasite antigens cross-
presented by activated brain endothelium (Belnoue et al, 2002;
Howland et al, 2013, 2015b) and mediate the disruption of the BBB
during PbA infection (Howland et al, 2015a). Since cross-presenta-
tion of parasite antigens is dependent on the parasite load in the
brain (Howland et al, 2013), and a reduced parasite load was
observed upon co-infection (Fig 2C), we assessed whether this influ-
enced the degree of parasite antigens cross-presentation in the brain
endothelium of co-infected mice. Using a reporter cell line to
measure the level of in vivo cross-presentation of an immunodomi-
nant “Pb1” parasite epitope by brain endothelial cells (Howland
▸Figure 1. Concurrent co-infection with CHIKV and PbA protects mice against ECM.A Parasitemia and mortality curve of PbA (n = 7) and PbA + CHIKV (n = 7) groups. PbA and CHIKV infection were given concurrently. Parasitemia data were analyzed
by Mann–Whitney two-tailed analysis (4 dpi; ***P = 0.0006). Mortality curve was analyzed by log-rank (Mantel–Cox) test (**P = 0.0081).
B Parasitemia and mortality curve of PbA (n = 6) and PbA (4 dpi) + CHIKV (n = 7) groups. CHIKV infection was given on 4 days post-PbA infection. Mortality curve was
analyzed by log-rank (Mantel–Cox) test (ns: P = 0.7425).
C Parasitemia and mortality curve of PbA (n = 7) and PbA + CHIKV (4 dpi) (n = 5) groups. PbA infection was given on 4 days post-CHIKV infection. Parasitemia data
were analyzed by Mann–Whitney two-tailed analysis (3 dpi; **P = 0.0025, 4 dpi; **P = 0.0025, 5 dpi; *P = 0.0101, 6 dpi; *P = 0.0177). Mortality curve was analyzed
by log-rank (Mantel–Cox) test (ns: P = 0.1180).
D Parasitemia and mortality curve of PbA (n = 5) and CHIKV recovered + PbA (n = 4) groups. PbA infection was given on day 15, after mice recovered from CHIKV-
induced joint-swelling on day 14. Mortality curve was analyzed by log-rank (Mantel–Cox) test (ns: P = 0.2923).
Data information: Shaded region within the graphs represents the ECM time window. Schematics of infection schedule are shown above each figure panel. Data shown
are representative of two independent experiments. Parasitemia data are represented as mean  SD.
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et al, 2013), we showed that co-infection greatly reduced cross-
presentation (Fig 3A).
Co-infection prevents sequestration of pathogenic CD8+ T cells
in the brain
A lower level of recruitment of CD45+ leukocytes into the brain was
observed during co-infection (Fig 3B). Among these CD45+ cells, both
total and activated (LFA-1+) CD4+ T cells and CD8+ T cells were
significantly less in the co-infected mice at 6 dpi (Fig 3C and D).
Particularly, co-infection was demonstrated to reduce the accumula-
tion of CD8+ T cells specific for a highly immunogenic parasite CD8+
T-cell epitope, Pb1 (Howland et al, 2013), in the brain (Fig 3E).
Co-infection does not impair priming and expansion of functional
CD8+ T cells in the spleen
Reduced accumulation of CD8+ T cells in the brain could result
from impaired priming and expansion in the spleen, or altered
T-cell trafficking to the brain. To address the first scenario, spleens
were isolated at 6 dpi and profiled for the level of induced T cells.
Surprisingly, it was observed that concurrent co-infection with
virus enlarged the spleen even more than single infection with
PbA (Fig 4A). This phenomenon was associated with higher
numbers of total splenocytes in the co-infected mice (Fig 4A).
Phenotyping by flow cytometry revealed that more activated total
(LFA-1+) CD4+ T cells and CD8+ T cells were present in the
enlarged spleens of co-infected mice (Fig 4B and C). Similarly, the
levels of Pb1-specific CD8+ T cells in the spleen were also higher
in the co-infected mice than in single PbA-infected mice (Fig 4D).
To confirm that the CD8+ T cells induced in the spleen of
co-infected mice are functional, an in vivo cytolysis assay was
performed. In both single PbA-infected and co-infected mice,
> 95% of transferred Pb1-pulsed naı¨ve splenocytes were elimi-
nated (Fig 4E), demonstrating that CD8+ T cells induced in the
spleens of co-infected mice are cytolytic. These results suggest that
co-infection does not impair the host’s ability to generate func-
tional T cells in the spleen.
A
C D
B
Figure 2. Concurrent co-infection prevents sequestration of parasites and BBB permeability in the brain.
A, B Parasite load in the whole body and head of PbA (n = 7) and PbA + CHIKV (n = 7) groups. Data shown were representative of two independent experiments.
Mann–Whitney two-tailed analysis (whole body—5 dpi; *P = 0.0379, head—5 dpi; ***P = 0.0006).
C Ex vivo parasite load in the brain of PbA (n = 4) and PbA + CHIKV (n = 5) groups on 6 dpi. Representative pseudoimages from each group are shown. Mann–
Whitney two-tailed analysis (*P = 0.159).
D Evans blue permeability assay for BBB in naïve (n = 9), CHIKV only (n = 7), PbA (n = 7), and PbA + CHIKV (n = 7) on 6 dpi. Representative images of the brain
after Evans blue injection from infected groups are shown. Data shown were pooled from two independent experiments. Kruskal–Wallis test with Dunn’s
multiple comparison test (naïve versus PbA; *mean rank diff = 13.06, CHIKV versus PbA; ***mean rank diff = 19.36, PbA versus PbA + CHIKV; *mean rank
diff = 13.14).
Data information: All data are expressed as mean  SD.
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Figure 3. Concurrent co-infection prevents T-cell sequestration and microvessel cross-presentation in the brain.
A Brain microvessel cross-presentation for Pb1 epitopes in naïve (n = 5), PbA (n = 5) and PbA + CHIKV (n = 5) groups on 6 dpi. One-way ANOVA with Tukey’s
post-test (naïve versus PbA; **mean diff = 922.8, PbA versus PbA + CHIKV; **mean diff = 888.2).
B–D CD45+, total and LFA-1+CD4+ T cells, and total and LFA-1+CD8+ T cells in the brain of naïve (ochre, n = 8), CHIKV (green, n = 7), PbA (red, n = 6), and PbA + CHIKV
(blue, n = 5) groups on 6 dpi. Data shown were representative of two independent experiments. All data were analyzed by one-way ANOVA with Tukey’s post-test.
For CD45+ cells (B): naïve versus PbA; **mean diff = 142,082, CHIKV versus PbA; **mean diff = 145,113, PbA versus PbA + CHIKV; *mean diff = 120725. For total
CD4+ T cells (C, left): naïve versus PbA; ***mean diff = 12,000, CHIKV versus PbA; **mean diff = 11,360. For LFA-1+CD4+ T cells (C, right): naïve versus PbA;
***mean diff = 7,828, CHIKV versus PbA; **mean diff = 7,243, PbA versus PbA + CHIKV; *mean diff = 4,521. For total CD8+ T cells (D, left): naïve versus PbA;
***mean diff = 65,880, CHIKV versus PbA; ***mean diff = 64,730, PbA versus PbA + CHIKV; **mean diff = 46,430. For LFA-1+CD8+ T cells (D, right): naïve versus
PbA; ***mean diff = 57,400, CHIKV versus PbA; ***mean diff = 56,280, PbA versus PbA + CHIKV; **mean diff = 39,320.
E Parasite epitope (Pb1)-specific CD8+ T cells in the brain of PbA (n = 6) and PbA + CHIKV (n = 5) groups on 6 dpi. Data shown were representative of two
independent experiments. Mann–Whitney two-tailed analysis (*P = 0.0303).
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Figure 4. Normal priming and expansion of functional T cells in the spleen during concurrent co-infection.
A–C Total splenocytes, total and LFA-1+CD4+ T cells, and total and LFA-1+CD8+ T cells in the spleen of naïve (n = 8), CHIKV (n = 7), PbA (n = 6), and PbA + CHIKV (n = 6)
groups on 6 dpi. (A) Representative images of spleens isolated on 6 dpi showing spleen enlargement during concurrent co-infection are shown. Total splenocytes
were determined by live cell count with Trypan blue staining. Data shown are representative of two independent experiments. All data were analyzed by one-way
ANOVA with Tukey’s post-test. For total splenocytes (A): naïve versus PbA; *mean diff = 5.5 × 107, naïve versus PbA + CHIKV; ***mean diff = 1.142 × 108, CHIKV
versus PbA; **mean diff = 6.993 × 107, CHIKV versus PbA + CHIKV; ***mean diff = 9.924 × 107, PbA versus PbA + CHIKV; ***mean diff = 1.692 × 108. For total
CD4+ T cells (B, left): naïve versus PbA + CHIKV; ***mean diff = 1.866 × 107, CHIKV versus PbA + CHIKV; ***mean diff = 1.621 × 107, PbA versus PbA + CHIKV;
***mean diff = 3.11 × 107. For LFA-1+CD4+ T cells (B, right): naïve versus PbA + CHIKV; ***mean diff = 1.056 × 107, CHIKV versus PbA + CHIKV; ***mean
diff = 8.321 × 106, PbA versus PbA + CHIKV; ***mean diff = 1.119 × 107. For total CD8+ T cells (C, left): naïve versus PbA + CHIKV; ***mean diff = 1.250 × 107,
CHIKV versus PbA + CHIKV; ***mean diff = 1.203 × 107, PbA versus PbA + CHIKV; ***mean diff = 1.770 × 107. For LFA-1+CD8+ T cells (C, right): naïve versus
PbA + CHIKV; ***mean diff = 9.094 × 106, CHIKV versus PbA + CHIKV; ***mean diff = 8.109 × 106, PbA versus PbA + CHIKV; ***mean diff = 7.687 × 106.
D Parasite epitope (Pb1)-specific CD8+ T cells in the spleen of PbA (n = 4) and PbA + CHIKV (n = 5) groups on 6 dpi. Data shown are representative of two
independent experiments. Mann–Whitney two-tailed analysis (*P = 0.0159).
E Representative plot of in vivo cytotoxic assay of naive (n = 2), PbA (n = 4) and PbA + CHIKV (n = 7). Equal numbers of CFSEhi unpulsed naive splenocytes and
CFSElo SQLLNAKYL (Pb1) pulsed splenocytes were transferred into the mice on 6 dpi. All mice from PbA and CHIKV + PbA groups showed > 95% of specific lysis on
Pb1 pulsed donor cells. Red arrows indicate pulsed splenocytes that were lysed.
Data information: All bar graphs are expressed as mean + SD.
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Concurrent co-infection reduces the migration capacity of CD8+
T cell to the brain and suppresses surface expression of CXCR3
and CD43
The higher number of functional CD8+ T cells in the spleens of co-
infected mice prompted us to test the capacity of these CD8+ T cells
to migrate to the brain during co-infection. We designed an in vivo
migration assay where equal number of CD8+ T cells isolated from
the splenocytes of either single PbA-infected donors or co-infected
donors at 6 dpi was adoptively transferred into single PbA-infected
recipient mice at 5 dpi. Migration capacity of total LFA-1 or Pb1-
specific CD8+ T cells originating from the infected donors was
quantified 22 h post-transfer by comparing the ratio of recovered
infected donor cells in the brain to the numbers of cell initially
transferred into the recipient. Interestingly, LFA-1+ and Pb1-specific
CD8+ T cells originating from the co-infected donors migrated less
efficiently to the brain than cells from single PbA-infected donors
(Fig 5A).
To understand how co-infection alters the migration capacity of
CD8+ T cells toward the brain, splenic CD8+ T cells were sorted
and quantified by gene expression using NanoString (Geiss et al,
2008). Compared to single PbA-infected mice, cd43, cd44, cd29, vla-
4, lfa-1, cd62L, cxcr3, cxcr4, cxcr5, cxcr6, ccr5, ccr7, and ccr9 genes
were differentially expressed in the co-infected mice (Appendix Fig
S1A). We then assessed the surface expression of these gene prod-
ucts on parasite-specific CD8+ T cells using flow cytometry
(Appendix Fig S1B and C). The only differences observed between
the splenic Pb1-specific CD8+ T cells of single PbA-infected and co-
infected mice were lower expression of CD43 and CXCR3 in the
latter (Fig 5B and Appendix Fig S1C).
The possible roles of these two markers during co-infection were
further investigated in detail. Although CD43 was previously shown
to be important for T-cell trafficking to the brain during viral infec-
tion (Onami et al, 2002), the role of CD43 in ECM induction is
unknown. Here, co-infection reduced the expression of CD43 in
splenic CD8+ T cells and decreased the number of CD43+ CD8+ T
cells in the brain (Appendix Fig S2A and B). To decipher the role of
CD43 in ECM, CD43/ mice were infected with PbA. These mice
developed ECM just like wild-type mice (Appendix Fig S2C and D),
demonstrating that this molecule is dispensable for ECM. Hence,
reduced expression of CD43 is unlikely to be the cause of ECM
protection during concurrent co-infection.
Co-infection does not affect migration of CD8+ T cell to CXCR3
chemokines despite suppression of CXCR3
Unlike CD43, the importance of the chemokine receptor CXCR3 for
CD8+ T-cell migration to the brain during ECM has been clearly
established (Campanella et al, 2008; Miu et al, 2008; Van den Steen
et al, 2008). During co-infection, CD8+ T cells had lower CXCR3
levels in the spleen, with the difference being especially stark in
Pb1-specific CD8+ T cells (Fig 5B and C). In addition, higher
numbers of CXCR3+CD8+ T cells were observed in the spleen of
co-infected mice although the number of CXCR3+ Pb1-specific
CD8+ T cells was similar (Fig 5D). To test whether this suppression
of CXCR3 surface levels affects the ability of CD8+ T cells to migrate
in response to its cognate chemokines, Transwell migration assays
were performed with isolated CD8+ T cells from the spleen (Fig 5E
and F). Surprisingly, despite having a reduced CXCR3 surface
expression, the LFA-1+ (activated) and Pb1-specific CD8+ T cells
from co-infected mice were not impaired in their ability to migrate in
response to CXCL9 and CXCL10 (Fig 5E and F). Given the lack of
CXCL11 in C57BL/6J mice (Carr et al, 2008), CXCL11-dependent
migration was not tested.
Co-infection enhances splenic CXCL9 and CXCL10 levels to induce
splenic retention of T cells
The reduced CXCR3 surface levels on CD8+ T cells in co-infected
mice could be the outcome and not the cause for the impaired
spleen-to-brain migration. It has been previously shown that CXCR3
is internalized in response to high ligand levels (Colvin et al, 2004;
Meiser et al, 2008). In addition, we have previously observed that
during ECM, CXCR3 surface levels on CD8+ T cells were lower in
the brain than in the spleen (Poh et al, 2014), presumably because
of higher CXCL9 and CXCL10 levels in the brain. We thus hypothe-
sized that during CHIKV-PbA co-infection, higher levels of CXCR3-
cognate chemokines may be induced in the spleen to mediate
splenic retention of CD8+ T cells and internalization of surface
CXCR3. Indeed, significantly higher levels of CXCL9 and CXCL10
were found in the spleen in the co-infected mice at 6 dpi (Fig 6A
and B). In contrast, similar levels of CXCL9 and CXCL10 levels were
observed in the brain of single PbA-infected and co-infected mice at
6 dpi (Fig 6C).
To verify whether co-infection altered the chemotactic environ-
ment in the spleen and favored retention of T cells, an in vivo
splenic retention assay was developed, where pooled CFSE-labeled
splenocytes were transferred from single PbA-infected donors into
either single PbA-infected or co-infected recipients at 5 dpi. Profiling
of donor CD8+ T cells retained in the recipients’ spleen was done
22 h post-transfer. More donor CD8+ T cells were found in the
spleens of co-infected mice compared to single PbA-infected mice
(Fig 6D–F). In particular, splenic retention of LFA-1+ (activated)
and Pb1-specific CD8+ T cells in the co-infected recipients was
significantly higher (> 10-folds) than in single PbA-infected recipi-
ents (Fig 6E and F).
To further demonstrate that the increased splenic levels of
CXCR3-cognate chemokines mediated higher T-cell retention during
co-infection, the same assay was performed using single PbA-
infected CXCR3/ donors. Although the retention of CD8+ T cells
was still higher in the co-infected recipients when single PbA-
infected CXCR3/ donor splenocytes were used (Fig 6D–F), the
degree of increase in retention of LFA-1+ (activated) and Pb1-
specific CD8+ T cells was significantly reduced to only ~2–3-folds as
compared to a > 10-folds higher retention when WT donor spleno-
cytes were used (Fig 6E and F and Appendix Fig S3). Interestingly,
the retention of total and LFA-1+ CD4+ T cells was also higher in
the co-infected recipients (~5-folds), but their retention was not
dependent on CXCR3 (Appendix Fig S4).
Co-infection induces high levels of splenic IFNc to elevate
CXCL9/CXCL10 and suppress CXCR3 expression to limit brain
migratory capacity of CD8+ T cells
The major inducer of CXCL9 and CXCL10 is type I interferon and
IFNc (Carter et al, 2007; Groom & Luster, 2011). However, at 6 dpi,
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Figure 5. Concurrent co-infection abrogates CD8+ T-cell migratory capacity to the brain and surface expression of CXCR3 in the spleen.
A In vivo migration assay measuring the migratory capacity of total, LFA-1+, and Pb1-specific CD8+ T cells from PbA donors (n = 5) and PbA + CHIKV donors (n = 10)
toward the brain of PbA recipients. 5 × 106 isolated donors’ CD8+ T cells (6 dpi) were transferred into PbA recipient at 5 dpi and harvested 22 h post-transfer. All
data are expressed as ratio of recovered cells to initial numbers of cell transferred into the recipients for each specific cell type. Mann–Whitney two-tailed analysis
(LFA-1+CD8+ T cells: *P = 0.0193, Pb1-specific CD8+ T cells: *P = 0.0280). Data shown were pooled from two independent experiments.
B Representative histogram of CXCR3 expression in naïve CD8+ T cells, Pb1-specific CD8+ T cells from PbA mice, and Pb1-specific CD8+ T cells from co-infected mice is
shown. Dotted line represents threshold for delineating CXCR3+ cells.
C Surface expression of CXCR3 in total CD8+ T cells and Pb1-specific CD8+ T cells in the spleen of PbA (n = 6) and PbA + CHIKV (n = 7) on 6 dpi. Surface expression is
determined by the geometric mean of CXCR3 signal by flow cytometry. Data shown are representative of two independent experiments. Mann–Whitney two-tailed
analysis (total CD8+ T cells: **P = 0.0012, Pb1-specific CD8+ T cells: **P = 0.0012).
D Number of CXCR3+CD8+ T cells and CXCR3+Pb1+CD8+ T cells in the spleen of PbA (n = 6) and PbA + CHIKV (n = 7) on 6 dpi. Data shown are a representative of two
independent experiments. Mann–Whitney two-tailed analysis (Total CD8+ T cells: *P = 0.035).
E, F Transwell migration assay using CXCL9 and CXCL10 with isolated total CD8+ cells from PbA (n = 6) and PbA + CHIKV (n = 6) on 6 dpi. Chemotaxis index was
determined as the (cells across Transwell with CXCL9 or CXCL10/cells across Transwell without chemokines). Data shown are representative of two independent
experiments. Mann–Whitney two-tailed analysis (for CXCL10 total CD8+ T cells: **P = 0.0022).
Data information: All data expressed as mean  SD.
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Figure 6. Increased CXCL9/CXCL10 levels in the spleen of co-infected mice drive CXCR3-dependent splenic retention of CD8+ T cells.
A Levels of CXCL9 protein in the spleen of naïve, PbA, and PbA + CHIKV groups on 2, 4, and 6 dpi (n ≥ 5 per group). Each data point was obtained from 1 mouse.
Data comparison between PbA and PbA + CHIKV groups was done by Mann–Whitney two-tailed analysis (6 dpi; **P = 0.0079). Data shown were pooled from
three independent experiments.
B Levels of CXCL10 protein in the spleen of naïve, PbA, and PbA + CHIKV groups on 2, 4, and 6 dpi (n ≥ 5 per group). Each data point was obtained from 1 mouse.
Data comparison between PbA and PbA + CHIKV groups was done by Mann–Whitney two-tailed analysis (6 dpi; *P = 0.0317). Data shown were pooled from three
independent experiments.
C Levels of CXCL9 and CXCL10 level in the brain of PbA (n = 5) and PbA + CHIKV (n = 5) on 6 dpi.
D–F In vivo retention assay displaying fold increase in recovered donors’ cells relative to the mean of recovered cells in PbA recipients in the respective genetic
backgrounds for total, LFA-1+, and Pb1-specific CD8+ T cells in each recipient spleen. WT Donor?PbA recipient (n = 4), WT Donor?Co-infected (CoIF) recipient
(n = 5), CXCR3/ donor?PbA recipient (n = 4) and CXCR3/ donor?Co-infected recipient (n = 5). All data were analyzed by Mann–Whitney two-tailed analysis.
For total CD8+ T cells (D): WT donor?PbA recipient versus WT donor?CoIF recipient; *P = 0.0159, CXCR3/ donor?PbA recipient versus CXCR3/ donor?CoIF
recipient; *P = 0.0159. For LFA-1+CD8+ T cells (E): WT donor?PbA recipient versus WT donor?CoIF recipient; *P = 0.0159, CXCR3/ donor?PbA recipient versus
CXCR3/ donor?CoIF recipient; *P = 0.0159, WT donor?CoIF recipient versus CXCR3/ donor?CoIF recipient; *P = 0.0159. For Pb1-specific CD8+ T cells (F): WT
donor?PbA recipient versus WT donor?CoIF recipient; *P = 0.0159, WT donor?CoIF recipient versus CXCR3/ donor?CoIF recipient; **P = 0.0079.
Data information: Chemokine protein levels were determined as pg per lg of total protein, measured by ELISA using cell lysate from the spleen in (A and B) or brain in (C).
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the time point where CXCL9 and CXCL10 are elevated in co-infected
mice, type I interferon is suppressed in CHIKV-infected mice while
IFNc is highly induced (Teo et al, 2015). In addition, we showed
that IFNc was induced in the spleen of single-CHIKV-infected mice
at 6 dpi (Appendix Fig S5). As such, we investigated whether higher
levels of these chemokines in the spleens of co-infected mice could
be attributed to higher IFNc levels locally induced in the spleen.
ELISA results from splenocytes lysate showed that more IFNc was
present in the spleens of co-infected mice at 6 dpi compared to
singly PbA-infected mice (Fig 7A).
To further demonstrate the causal relationship between IFNc and
CXCL9/CXCL10 induction in the co-infected mice, we performed co-
infection in IFNc/ mice. Similar to previous study, ECM does not
occur in IFNc/ mice (Claser et al, 2011); hence, ECM was not
recapitulated in the co-infected IFNc/ mice (Appendix Fig S6).
However, induction of splenic CXCL9 (~10-fold reduction) and
CXCL10 (~4-fold reduction) was abolished in co-infected
IFNc/ mice (Fig 7B and C) and restored the numbers of splenic
total and Pb1-specific CD8+ T cells. CXCR3 expression in the
co-infected IFNc/ mice was similar to single PbA-infected mice
(Fig 7D–F). Importantly, when isolated CD8+ T cells (6 dpi) from
single PbA-infected or co-infected donors in IFNc/ background
were transferred into WT PbA-infected recipients, a similar propor-
tion of LFA-1+ and Pb1-specific CD8+ T cells was recovered in the
recipient brains (Fig 7G), suggesting a restoration of migration
capacity of these CD8+ T cells in the IFNc/ co-infected donor.
Splenic CD4+ T cells is the major contributor of IFNc
during co-infection
To identify leukocyte subsets responsible for the higher levels of
splenic IFNc during co-infection, intracellular staining for IFNc was
performed on splenocytes harvested on 6 dpi. CD4+ T cells, CD8+
T cells, NK cells, NKT cells, and neutrophils were identified to be
the main IFNc producers in the spleen (Fig 8A). Interestingly, only
CD4+ T cells showed the most prominent induction of IFNc
expression and increase in IFNc+ numbers upon co-infection
(Fig 8). Co-infection did not alter IFNc expression in CD8+ T cells.
Total and IFNc-producing NK cells were reduced with parasite
infection. IFNc-producing NKT cells were a minor producing subset
in comparison with other subsets (Fig 8); hence, they are unlikely
to be the major contributors to this phenomenon. For neutrophils,
while IFNc expression is high in all four groups, the difference
between single PbA infection and co-infection was a result of
neutrophils reduction in single PbA infection and not an increase in
IFNc expression level in the co-infected mice (Fig 8). Taken
together, CD4+ T cells are the major contributors of higher splenic
IFNc during co-infection.
Discussion
Worms [Schistosoma sp (Hartgers & Yazdanbakhsh, 2006; Waknine-
Grinberg et al, 2010; Bucher et al, 2011; Wang et al, 2013, 2014),
Litomosoides sigmodontis (Karadjian et al, 2014), and Heligmoso-
moides polygyrus (Su et al, 2005)] and bacteria [Mycobacterium
tuberculosis (Li & Zhou, 2013), Listeria monocytogenes (Qi et al,
2013), and Salmonella (Cunnington et al, 2012)] have been shown
to alter the pathological outcome of malaria infection through
bystander regulation of the host immunity. Specific to the PbA-ECM
model, the mechanisms leading to ECM protection during co-infec-
tion were mostly due to the suppression of the pro-inflammatory
response induced by the heterologous pathogen, which occurs from
4 days post-Plasmodium infection onwards. In helminth–Plasmod-
ium co-infection, S. japonicum (Wang et al, 2013, 2014) and
S. mansoni (Waknine-Grinberg et al, 2010; Bucher et al, 2011)
protected co-infected mice from ECM by inducing a Th2-polarizing
response in the host, shifting the balance away from the Th1
response that is essential for ECM to occur. In nematode–Plasmod-
ium co-infection, L. sigmodontis induced an anti-inflammatory IL-10
response in the co-infected host, which counteracted the Th1
response and protected the host from ECM (Specht et al, 2010).
▸Figure 7. Elevated splenic IFNc during co-infection induces splenic CXCL9/CXCL10 and suppresses CXCR3 expression on CD8+ T cells to limitmigration capacitytoward the brain.
A Levels of IFNc protein in the spleen of naïve, PbA, and PbA + CHIKV groups on 2, 4, and 6 dpi (n ≥ 5 per group). Data comparison between PbA and PbA + CHIKV
groups was done by Mann–Whitney two-tailed analysis (6 dpi; *P = 0.0317).
B, C Levels of CXCL9 and CXCL10 protein in the spleen of WT naïve (n = 5), WT + PbA (n = 5), WT + PbA + CHIKV (n = 5), IFNc/ + PbA (n = 4), and
IFNc/ + PbA + CHIKV (n = 4) on 6 dpi. Data comparison between PbA and PbA + CHIKV groups in the respective WT and IFNc/ background was done by
Mann–Whitney two-tailed analysis (CXCL9–WT + PbA versus WT + PbA + CHIKV; *P = 0.0238, IFNc/ + PbA versus IFNc/ + PbA + CHIKV; nsP = 0.7429.
CXCL10–WT + PbA versus WT + PbA + CHIKV; **P = 0.0079, IFNc/ + PbA versus IFNc/ + PbA + CHIKV; nsP = 0.3429).
D Number of total CD8+ T cells and Pb1-specific CD8+ T cells in the spleen of WT + PbA (n = 5), WT + PbA + CHIKV (n = 4), IFNc/ + PbA (n = 5), and
IFNc/ + PbA + CHIKV (n = 6) on 6 dpi. Data comparison between PbA and PbA + CHIKV groups in the respective WT and IFNc/ background was done by
Mann–Whitney two-tailed analysis (total CD8+ T cells–WT + PbA versus WT + PbA + CHIKV; *P = 0.0159, IFNc/ + PbA versus IFNc/ + PbA + CHIKV;
nsP = 0.0823, Pb1-specific CD8+ T cells–WT + PbA versus WT + PbA + CHIKV; *P = 0.0317, IFNc/ + PbA versus IFNc/ + PbA + CHIKV; nsP = 0.4286).
E, F CXCR3 surface expression on total CD8+ T cells and Pb1-specific CD8+ T cells in the spleen of WT + PbA (n = 5), WT + PbA + CHIKV (n = 4), IFNc/ + PbA (n = 5),
and IFNc/ + PbA + CHIKV (n = 6) on 6 dpi. Representative histograms showing CXCR3 expression are shown. Threshold of CXCR3+ cells is delineated by black
dotted line. Data comparison between PbA and PbA + CHIKV groups in the respective WT and IFNc/ background was done by Mann–Whitney two-tailed
analysis (total CD8+ T cells–WT + PbA versus WT + PbA + CHIKV; *P = 0.0159, IFNc/+ PbA versus IFNc/ + PbA + CHIKV; nsP = 0.0823, Pb1-specific CD8+
T cells–WT + PbA versus WT + PbA + CHIKV; *P = 0.0159, IFNc/ + PbA versus IFNc/ + PbA + CHIKV; nsP = 0.9307).
G In vivo migration assay measuring the migratory capacity of LFA-1+ and Pb1-specific CD8+ T cells from IFNc/ + PbA donors (n = 4) and IFNc/ + PbA + CHIKV
donors (n = 3) toward the brain of WT PbA recipients. 7 × 106 isolated donors’ CD8+ T cells (6 dpi) were transferred into PbA recipient at 5 dpi and harvested 22 h
post-transfer. All data are expressed as ratio of recovered cells to initial numbers of cell transferred into the recipients for each specific cell type. Mann–Whitney
two-tailed analysis (LFA-1+CD8+ T cells: nsP = 0.9999, Pb1-specific CD8+ T cells: nsP = 0.6286).
Data information: For all cytokines or chemokines, quantifications were measured by ELISA using cell lysate from the organ and determined as pg/lg of total protein.
Each data point shown in the dot plots was obtained from 1 mouse.
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Similarly, the murine AIDS virus was reported to protect against
ECM by inducing splenic CD4 T cells to express IL-10 (Eckwalanga
et al, 1994).
We show in this study that concurrent co-infection with CHIKV
also protected the host from ECM. A novel interfering mechanism
was identified whereby co-infection with CHIKV alters the traf-
ficking of pathogenic parasite-specific CD8+ T cells (Fig 8). In
particular, concurrent co-infection with CHIKV abolishes early
migration of CD8+ T cells to the brain. Instead, these cells are
retained in the spleen, thus protecting co-infected mice from ECM-
induced neuropathology. Co-infection induces higher IFNc levels in
the spleen compared to single PbA infection. The higher IFNc is
likely generated by IFNc-producing CHIKV-specific CD4+ T cells in
the spleen which was previously shown to be elevated on 6 days
A
D
G
E
F
B C
Figure 7.
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Figure 8. Increased IFNc producing CD4+ T cells in the spleen drives the enhanced splenic IFNc on 6 dpi during concurrent co-infection.
A Representative histogram showing IFNc production in CD4+ T cells, CD8+ T cells, NK cells, NKT cells, and neutrophils in the spleen of naïve (n = 5), CHIKV (n = 5), PbA
(n = 6), and PbA + CHIKV (n = 8) on 6 dpi. Black dotted line represents threshold setting for IFNc+ cells.
B Numbers of CD4+ T cells, CD8+ T cells, NK cells, NKT cells, and neutrophils in the spleen of naïve (n = 5), CHIKV (n = 5), PbA (n = 6), and PbA + CHIKV (n = 8) on 6 dpi.
CD4+, CD8+ T cells, NK cells, NKT cells, and neutrophils were defined as CD3+CD4+, CD3+CD8+, CD3NK1.1+, CD3+NK1.1+, and CD3CD11b+Ly6G+ cells, respectively. All
data analyzed by one-way ANOVA with Tukey’s post-test. For CD4+ T cells: naïve versus PbA + CHIKV; *mean diff = 1.49 × 107, PbA versus PbA + CHIKV; *mean
diff = 1.57 × 107. For CD8+ T cells: naïve versus PbA + CHIKV; *mean diff = 9.61 × 106, CHIKV versus PbA + CHIKV; *mean diff = 9.43 × 106, PbA versus
PbA + CHIKV; *mean diff = 9.75 × 106. For NK cells: naïve versus PbA; ***mean diff = 5.22 × 106, naïve versus PbA + CHIKV; **mean diff = 4.03 × 106, CHIKV versus
PbA; ***mean diff = 5.39 × 106, CHIKV versus PbA + CHIKV; **mean diff = 4.20 × 106. For NKT cells: naïve versus PbA; *mean diff = 7.95 × 105, CHIKV versus PbA;
*mean diff = 7.34 × 105, PbA versus PbA + CHIKV; **mean diff = 8.19 × 105. For neutrophils: naïve versus PbA; *mean diff = 1.51 × 106, CHIKV versus PbA; *mean
diff = 1.34 × 106, CHIKV versus PbA + CHIKV; *mean diff = 1.32 × 106, PbA versus PbA + CHIKV; ***mean diff = 2.66 × 106.
C Numbers of IFNc-producing CD4+ T cells, CD8+ T cells, NK cells, NKT cells, and neutrophils in the spleen of naïve (n = 5), CHIKV (n = 5), PbA (n = 6) and PbA + CHIKV
(n = 8) on 6 dpi. All data analyzed by one-way ANOVA with Tukey’s post-test. For IFNc+CD4+ T cells: naïve versus PbA + CHIKV; ***mean diff = 5.99 × 106, CHIKV
versus PbA + CHIKV; ***mean diff = 5.52 × 106, PbA versus PbA + CHIKV; ***mean diff = 3.95 × 106. For IFNc+CD8+ T cells: naïve versus PbA + CHIKV; *mean
diff = 9.28 × 105, CHIKV versus PbA + CHIKV; **mean diff = 1.08 × 106. For IFNc+ NK cells: naïve versus CHIKV; ***mean diff = 1.83 × 105, naïve versus PbA;
***mean diff = 2.81 × 105, naïve versus PbA + CHIKV; ***mean diff = 2.83 × 105. For IFNc+ NKT cells: naïve versus PbA + CHIKV; *mean diff = 68295, CHIKV versus
PbA + CHIKV; **mean diff = 93362, PbA versus PbA + CHIKV; **mean diff = 80084. For IFNc+ neutrophils: naïve versus PbA; *mean diff = 1.58 × 106, CHIKV versus
PbA; *mean diff = 1.40 × 106, PbA versus PbA + CHIKV; ***mean diff = 2.50 × 106.
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post-CHIKV infection (Teo et al, 2017). We propose that the higher
levels of splenic IFNc in these co-infected mice drive higher local
production of CXCL9 and CXCL10 (Carter et al, 2007). This
promotes splenic retention of pathogenic CD8+ T cells induced in
the spleen and reduces trafficking of these cells to the brain.
Furthermore, in line with a previous study showing that CD8+
T cells regulate parasite sequestration in the brain (Claser et al,
2011), co-infected mice have lower parasite loads in the brain and
hence diminish brain endothelial cross-presentation of parasite anti-
gens. With lesser parasite-specific CD8+ T cells and fewer cross-
presenting targets of endothelial cells, BBB integrity is preserved,
thereby protecting mice from ECM.
While the drastic differences between co-infected and PbA-
infected mice in the splenic retention assay suggest that chemokine
milieu in the spleen is primarily responsible for the altered T-cell
migration patterns, there remains a minor role for differences in the
migration capacity of the CD8+ T cells themselves. A modest
decrease in the ability of adoptively transferred CD8+ T cells from
co-infected donors to migrate to the brains of PbA-infected recipi-
ents was observed as compared to single PbA-infected donors.
Extensive phenotyping found two molecules that could have a role
behind this reduced migration capacity in vivo. Of the two mole-
cules found to be differentially expressed in the parasite-specific
CD8+ T cells of co-infected, CD43 was found to be dispensable for
ECM, whereas the reduced surface expression levels of CXCR3 did
not affect the ability of these cells to migrate in vitro in response
to CXCL9 and CXCL10. Instead, the low level of surface CXCR3
expression on the splenic CD8+ T cells of co-infected mice is likely
to be a consequence of high exposure to CXCL9 and CXCL10 in
the spleen, leading to receptor internalization and degradation
(Colvin et al, 2004; Meiser et al, 2008). In addition to CXCL9 and
CXCL10, other chemokines may also be highly induced by IFNc in
the spleens of co-infected mice. This can be deduced by the results
of the in vivo splenic retention assay using donor cells deficient in
CXCR3, where the enhanced ability of the co-infected mouse
spleens to attract the CD8+ T cells was largely, but not completely
abrogated.
While co-infection with CHIKV is protective in the context of
ECM, co-infection of CHIKV with other pathogens could be detri-
mental if CD8+ T cells are needed for protection in the peripheral
tissues. In contrast to their pathogenicity in ECM, CD8+ T cells
are needed for protection against a wide spectrum of neurological
Figure 9. Proposed mechanism of ECM protection during concurrent co-infection of PbA and CHIKV.
In normal PbA infection (shown on the left) in susceptible C57BL/6J, parasite-specific pathogenic CD8+ T cells are generated in the spleen. These CD8+ T cells migrate to
the brain and interact with brain endothelia cross-presenting parasite proteins, leading to cytotoxic events that alter the BBB, causing eventual death. Pathogenic events
in the brain are highlighted in italics brown font. In concurrent co-infection with PbA and CHIKV (shown on the right), increased IFNc production is induced in splenic
CD4+ T cells. This drives the enhanced production of CXCL9 and CXCL10 in the spleen. Increased CXCR3–chemokine interaction leads to internalization and retention of
CXCR3 on the pathogenic CD8+ T cells in the spleen. This reduces migration of these cells into the brain and abrogates downstream pathogenic events mediated by parasite-
specific CD8+ cells. Pathogenic events suppressed during co-infection are highlighted in gray font.
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infections including West Nile virus (Klein et al, 2005; Brien et al,
2007), human simplex virus-1 (Lang & Nikolich-Zugich, 2005),
cytomegalovirus (Bantug et al, 2008), enterovirus 71 (Lin et al,
2009), Toxoplasma gondii (Guiton et al, 2009), neuroborreliosis
(Jacobsen et al, 2003), and central nervous system listeriosis
(Schluter et al, 1995; Hayashi et al, 2009). The IFNc-dependent
mechanism described here induced by co-infection with CHIKV
could possibility alter or delay CD8+ T-cell migration to the brain,
leading to disease aggravation. The ECM results here underscore
the importance of further studies into the regulation and function
of T-cell migration in the context of CHIKV co-infection with other
pathogens. Such co-infections may interfere with protective or
pathogenic immune responses induced by single infection. Under-
standing the interfering mechanisms will pave the way in the
development of new therapeutic modalities. Lastly, it also calls for
comprehensive pathogen identification in endemic countries when
symptomatic diagnosis of one pathogen may be confounded by
another pathogen.
Materials and Methods
Mice
Six-week-old male or female CD45.2, IFNc/, CXCR3/, and
CD43/ mice in C57BL/6J background were used. CD43/ mice
in B6;129 background was purchased from Jackson Lab and back-
crossed for three generations with C57BL/6J to obtain CD43/ F3
generation before use in any experiments. All mice were bred and
kept under specific pathogen-free conditions in the Biological
Resource Centre, Agency for Science, Technology and Research,
Singapore. All experiments and procedures were approved by the
Institutional Animal Care and Use Committee (IACUC: 140968) of
the Agency for Science, Technology and Research, Singapore, in
accordance with the guidelines of the Agri-Food and Veterinary
Authority and the National Advisory Committee for Laboratory
Animal Research of Singapore.
Pathogens and infection
The transgenic P. berghei ANKA (231c1 l) line expressing luciferase
and green fluorescent proteins under control of the ef1-a (PbA-luc)
used in this study was kindly provided by Dr. Christian Engwerda
(Amante et al, 2007). Infected RBC (iRBC) was prepared through
in vivo passage in C57BL/6J mice and stored in Alsever’s solution in
liquid nitrogen (Claser et al, 2011).
The CHIKV strain used was isolated at the National University
Hospital from the 2008 outbreak in Singapore (Her et al, 2010).
CHIKV was propagated in C6/36 cultures and quantified by standard
plaque assay in Vero E6 cells (Teo et al, 2013). Mice were infected
with PbA-luc by inoculating 106 iRBC intraperitoneally (i.p.). CHIKV
was inoculated subcutaneously in the ventral side of the right hind
footpad toward the ankle with 1 × 106 PFU CHIKV in 30 ll PBS.
Infection parameters and ECM evaluation
Parasitemia was monitored by flow cytometry daily from 3 to 12 dpi
and subsequently on alternate days as previously described
(Malleret et al, 2011). Parasite accumulation in the whole body and
head was also measured daily using an in vivo bioluminescence
imaging system (IVIS Spectrum, Xenogen, Alameda, CA) as previ-
ously reported (Claser et al, 2011). Mice were considered to have
ECM if they display neurological symptoms such as paralysis, atax-
ia, deviation of the head, convulsion, coma, and died within the
ECM window of 6–12 dpi (Claser et al, 2011).
Determination of parasite sequestration in the brain
Mice were injected with 200 ll of D-luciferin potassium salt (Caliper
Life sciences) in PBS (5 mg/ml). After 2 min, mice were perfused,
and individual brains were removed and placed on petri dish. Biolu-
minescence signals were quantified by in vivo bioluminescence
imaging system (IVIS Spectrum, Xenogen, Alameda, CA) at field of
vision (FOV) C (13.1 cm; Claser et al, 2011).
Determination of BBB permeability
Evans blue permeability assay was used to quantify BBB permeabil-
ity. Briefly, each mouse was given 200 ll of 1% w/v Evans blue
(Sigma-Aldrich) in 0.9% w/v NaCl intravenously (i.v). After 1-h
incubation, the mouse was anesthetized and perfused, and the brain
was removed and placed in 1 ml of N,N-dimethylformamide
(Sigma-Aldrich). Samples were incubated at room temperature for
48 h, and absorbance readings of the supernatant were taken at
OD620 nm.
In vivo cytotoxic assay
In vivo cytolysis assay was conducted to test the cytotoxic capacity
of Pb1-specific (dominant CD8 epitope for PbA infection) CD8+ T
cells (Howland et al, 2013). Briefly, naive splenocytes were divided
into two portions. One portion was incubated with 10 lg/ml
SQLLNAKYL peptide for 1 h at 37°C and then washed and labeled
with 0.5 lM carboxy-fluorescein succinimidyl ester (CFSE) for
10 min at 37°C; the other portion was not pulsed with peptide and
labeled with 5 lM CFSE. Equal numbers of peptide-pulsed and
unpulsed splenocytes (107 cells each) were injected (i.v) into naive
mice, PbA-infected or PbA-CHIKV co-infected mice at 6 dpi. The
mice were sacrificed 20 h later to analyze the CFSE-labeled cells in
the spleen by flow cytometry.
Leukocytes profiling in the brain and spleen
Mice were sacrificed and perfused by intracardial injection of PBS at
6 dpi. Subsequently, the brain and spleen were extracted and
processed to obtain leukocytes as previously described (Claser et al,
2011; Teo et al, 2013). Isolated leukocytes were stained with LIVE/
DEAD Aqua (Life Technologies), then blocked in 100 ll of blocking
buffer consisting of a mix of 1% of rat and mouse serum (Sigma-
Aldrich) in FACS buffer [1% BSA, 2 lm EDTA in PBS]. Next, cells
were incubated with PE-labeled SQLLNAKYL-H-2Db (Pb-1) tetramer
(Howland et al, 2013) on ices before addition of conjugated antibod-
ies for another 20 min of incubation. Cells were fixed in IC fixation
buffer (ebioscience) for 5 min before acquisition using a LSR II flow
cytometer (BD Biosciences). Conjugated antibodies used were as
follows: a-CD45 (clone 30-F11, BD Biosciences, 1:400 dilution),
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a-CD3 (clone 17A2, BD Biosciences, 1:200 dilution), a-CD4 (clone
GK1.5, Biolegend, 1:400 dilution), a-CD8 (clone 53–6.7, BD Bios-
ciences, 1:400 dilution), a-LFA-1 (H155-78; Biolegend, 1:200 dilu-
tion), a-NK1.1 (clone PK136, ebioscience, 1:200 dilution), a-CD11b
(clone M1/70, Biolegend, 1:400 dilution), and a-Ly6G (clone 1A8,
Biolegend, 1:400 dilution). Gating strategy of T-cell infiltrate in the
brain is shown in Appendix Fig S7. Majority of the T-cell infiltrate
in the brain of the infected mice express LFA-1 marker
(Appendix Fig S7).
Brain microvessel cross-presentation assay
Brain microvessel cross-presentation assay for the Pb1 epitope of
PbA was performed as described previously at 6 dpi (Howland et al,
2013, 2015a). Briefly, mice were perfused and the brain (without
the meninges and brain stem) was finely minced with 1 ml of
medium and homogenized by passing five times through a 23-gauge
needle. The homogenate was mixed with an equal volume of 30%
dextran (MW ~70,000, Sigma-Aldrich) in PBS and centrifuged at
10,000 g for 15 min at 48°C. To retain the microvessels, the pellet
was resuspended in PBS and passed through a 40-mm cell strainer.
After washing to remove leukocytes, the cell strainer was back-
flushed with 2 ml PBS over a 6-well plate to collect the microves-
sels. Microvessels were rocked at room temperature with 2% FBS,
1 mg/ml of type 4 collagenase, and 10 mg/ml of DNase I for
90 min. The digested microvessels were added to 5 ml medium,
pelleted at 500 g for 5 min, resuspended in 500 ml of medium, and
divided between five wells of a 96-well filter plate. LR-BSL8.4a
reporter cells (3,104 cells in 100 ml) were added to each well before
the plate was incubated overnight and then stained with X-gal.
Degree of cross-presentation was quantified as blue spots using
“ImmunoSpot 5.0 Analyzer Professional DC” (Cellular Technology
Ltd).
In vivo migration assay
At 6 dpi, spleens from singly PbA-infected or co-infected donors
were harvested. Total CD8+ T cells were isolated from these
donors through negative selection with a CD8a+ T-cell isolation
kit (Miltenyi Biotec). Cells were subsequently labeled with 5 lM
of CFSE solution for 10 min, washed with PBS. A solution
containing 5 × 106 cells in 200 ll of PBS was injected i.v. into a
PbA-infected recipient at 5 dpi. A portion of these donor cells
were stained with a-CD45 (1:400), a-CD3 (1:200), a-CD4 (1:400),
a-CD8 (1:400), a-LFA-1 (1:200) antibodies and Pb1 tetramer
followed by flow cytometry acquisition to profile for the numbers
of total, LFA-1+ and Pb1-specific CD8+ T cells in the 5 × 106
donor cells. Twenty-two hours post-transfer, brains were extracted
from the recipient mice and processed to obtain cell suspension.
Extracted cells were stained with live/dead determination dye
(Invitrogen) for 20 min, followed by a-CD45 (1:400), a-CD3
(1:200), a-CD4 (1:400), a-CD8 (1:400), a-LFA-1 (1:200) antibodies,
and Pb1 tetramer and flow cytometry acquisition using a LSR II
flow cytometer. Migration capacity of the donor cells toward the
brain was determined by the ratio of donor cells obtained from
the recipient brain divided by initial number of donors cells
transferred. Schematic diagram of this assay is provided in
Appendix Fig S8.
Transwell chemotaxis assay for CD8+ T cells
On 6 dpi, splenocytes were isolated and CD8+ T cells were selected
through negative selection with a CD8a+ T cells isolation kit (Mil-
tenyi Biotec). 5-lm polyester membrane Transwell inserts (Corning)
were placed on a 24-well plate (Corning) containing 600 ll of RPMI
medium with 10% FBS and either no chemokines, 200 ng/ml of
CXCL9, or 200 ng/ml of CXCL10. 1 × 106 isolated CD8+ T cells
were added to the upper chamber in 100 ll of medium lacking
chemokines. The Transwell setup was incubated at 37°C for 3 h and
activated CD3+CD8+LFA-1+ or parasite-specific CD3+CD8+Pb1+
T cells that crossed the membrane were quantified by flow cytome-
try. The chemotaxis index of each CD8+ T-cell subset was deter-
mined by the ratio of cells recovered with chemokine-containing
medium to cells recovered with medium alone.
In vivo retention assay
At 6 dpi, splenocytes were isolated from PbA-infected donors,
pooled at 5 × 107 cells/ml and labeled in 5 lM CFSE solution for
10 min. After labeling and washing, 5 × 107 donor splenocytes in
200 ll PBS was injected i.v. into each PbA or PbA + CHIKV recipient
at 5 dpi. 22 h post-transfer, recipients’ splenocytes were harvested
and stained with a-CD45 (1:400), a-CD3 (1:200), a-CD4 (1:400),
a-CD8 (1:400), a-LFA-1 (1:200), and Pb1-specific tetramer.
Gene expression of splenic CD8+ T cells by NanoString
On 6 dpi, splenocytes were isolated and CD8+ T cells (CD3+CD8+
cells) were sorted (4-laser FACSAria III, BD Biosciences). Sorted cells
were immediately lysed in lysis buffer from RNeasy kit (Qiagen) and
kept at 80°C. Gene expression in 10,000–15,000 lysed cells was
quantified using the nCounter Mouse immunology kit (NanoString
Technologies) following the manufacturer’s protocols. Data were
analyzed and visualized by TIBCO Spotfire software (PerkinElmer).
Surface expression of chemokine receptors
Isolated splenocytes at 6 dpi were stained with LIVE/DEAD Aqua
followed by Pb-1-specific tetramer and surface markers staining.
The following antibodies were used: a-CD62L (clone MEL-14, Biole-
gend, 1:200 dilution), a-CXCR4 (clone 2B11, ebioscience, 1:200 dilu-
tion), a-CD43 (clone 1B11, Biolegend, 1:200 dilution), a-CD44
(clone 1M7, BD Biosciences, 1:200 dilution), a-CCR5 (clone HM-
CCR5, Biolegend, 1:200 dilution), a-CXCR3 (clone CXCR3-173,
ebioscience, 1:200 dilution), a-LFA-1 (H155-78; Biolegend, 1:200
dilution), and VLA-4 (clone R1-2, Biolegend, 1:200 dilution). Levels
of surface expression were determined by mean fluorescence inten-
sity (MFI).
Quantification of cytokine/chemokine proteins in cell lysate
by ELISA
Spleen and brain were extracted and homogenized in RIPA buffer
(50 mM Tris–HCl pH 7.4; 1% NP-40; 0.25% sodium deoxycholate;
150 mM NaCl; 1 mM EDTA) with 1× protease inhibitors (Roche)
using a micro-bead cell disrupter (Micro Smash MS-100, Digital Biol-
ogy) at 5,000 rpm for 1 min. Cell lysates were further sonicated at
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70% intensity for 15 s (Branson Ultrasonics SonifierTM S-450), and
supernatants were collected to quantify IFNc, CXCL9, and CXCL10
by ELISA (R&D systems). Total protein in each sample was deter-
mined by DC protein assay (Bio-rad) accordingly to kit protocol,
and IFNc, CXCL9, and CXCL10 levels were expressed as pg protein
of interest per lg of total protein. The detection limit of IFNc,
CXCL9, and CXCL10 ELISA assay was 31.3, 15.6, and 62.5 pg/ml,
respectively.
Intracellular staining of IFNc production in leukocyte subsets
Processed splenocytes were washed once in complete medium,
resuspended at 6 × 105 cells in 100 ll of complete medium with 1×
Brefeldin A (BD Biosciences), and incubated for 3 h at 37°C. Subse-
quently, cells were stained with live/dead determination dye (Invit-
rogen) for 20 min followed by surface marker staining [a-CD45
(1:400), a-CD3 (1:200), a-CD4 (1:400), a-CD8 (1:400), a-NK1.1
(1:200), aCD11b (1:400), and aLy6G (1:400)]. Labeled cells were
then fixed and permeabilized in cytoFix/Perm solution (BD Bios-
ciences) for 20 min at 4°C before staining with a-IFNc (clone
XMG1.2, ebioscience, 1:200 dilution) in cytoFix/Perm buffer for
30 min. Cells were then washed and resuspended for flow cytome-
try data acquisition.
Statistical analysis
All statistical analyses were performed according to the appropri-
ate test depending of the parametric or nonparametric
distribution of the data using Prism 6 (GraphPad Software). Test
of normality was done by D’Agostino-Pearson omnibus normality
test. All data with normal distribution were analyzed by
unpaired t-test or one-way ANOVA with Tukey’s post-test. All
data that do not meet the normality requirements were analyzed
with Mann–Whitney two-tailed analysis or Kruskal–Wallis with
Dunn’s multiple comparisons. P-values < 0.05 were considered
statistically significant.
Expanded View for this article is available online.
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